Skip to main content
. 2016 Nov 16;2016(11):CD008720. doi: 10.1002/14651858.CD008720.pub2

Summary of findings for the main comparison. Human chorionic gonadotrophin (hCG) priming for subfertile women undergoing in vitro maturation (IVM).

HCG priming versus no priming in women undergoing IVM treatment for subfertility
Population: Subfertile women undergoing in vitro maturation
 Setting: Assisted reproduction clinic
 Intervention: 10,000 units hCG
 Comparison: No priming
Outcomes Anticipated absolute effects* (95% CI) Relative effect
 (95% CI) No. of participants
 (studies) Quality of the evidence
 (GRADE) Comments
Risk with no priming Risk with 10,000 units hCG
Live Birth Rate Moderate (median) risk OR 0.65
 (0.24 to 1.74) 82
 (1 RCT) ⊕⊕⊝⊝
 LOW 1,2  
310 per 1000 226 per 1000
 (97 to 439)
Miscarriage Rate Moderate (median) risk OR 0.60
 (0.21 to 1.72) 282
 (2 RCTs) ⊕⊕⊝⊝
 LOW 1,2  
70 per 1000 43 per 1000
 (16 to 115)
Clinical Pregnancy Rate Moderate (median) risk OR 0.52
 (0.26 to 1.03) 282
 (2 RCTs) ⊕⊕⊝⊝
 LOW 1,2  
225 per 1000 131 per 1000
 (70 to 230)
Adverse events and drug reactions No study reported data on any adverse events (apart from miscarriage) nor on drug reactions    
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 
 CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;
GRADE Working Group grades of evidenceHigh quality: We are very confident that the true effect lies close to that of the estimate of the effect
 Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
 Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
 Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1. Downgraded one level due to serious imprecision ‐ low total number of events. Confidence intervals compatible with no difference between the arms, or with benefit in either arm.

2. Downgraded one level due to serious risk of bias ‐ high risk of performance bias in all studies, as participants not blinded (as placebo not used)